← Back to all clusters

Cluster 53

16 diseases · 45 shared-gene connections
16 Diseases
15 Unique genes
0.346 Avg. similarity score
Clapo syndrome Most-connected disease (11 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
PIK3CA 12 / 16 Capillary-lymphatic-venous malformation, Clapo syndrome, Cloves syndrome, Congenital hemihypertrophy and 8 more
EED 2 / 16 Cohen-gibson syndrome, Weaver syndrome
EZH2 2 / 16 Upper extremity deformity, congenital, Weaver syndrome
KIF1B 2 / 16 Charcot-Marie-Tooth disease type 2A1, Congenital hemihypertrophy
SH3TC2 2 / 16 Charcot-Marie-Tooth disease type 4C, Congenital hemihypertrophy
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
PKMTs methylate histone lysines Reactome 4 / 71 45.1× 1.46e-6 6.77e-5 ✓ sig.
Transcriptional Regulation by E2F6 Reactome 3 / 35 68.6× 1.01e-5 3.38e-4 ✓ sig.
Regulation of PTEN gene transcription Reactome 3 / 53 45.3× 3.56e-5 9.62e-4 ✓ sig.
PI3K/AKT activation Reactome 2 / 9 178× 5.22e-5 1.32e-3 ✓ sig.
VEGFA-VEGFR2 Pathway Reactome 3 / 62 38.7× 5.70e-5 1.42e-3 ✓ sig.
PRC2 methylates histones and DNA Reactome 3 / 73 32.9× 9.30e-5 2.11e-3 ✓ sig.
Bacterial invasion of epithelial cells KEGG 3 / 78 30.8× 1.13e-4 2.48e-3 ✓ sig.
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases Reactome 2 / 14 114× 1.31e-4 2.80e-3 ✓ sig.
Polycomb repressive complex KEGG 3 / 83 28.9× 1.36e-4 2.88e-3 ✓ sig.
EPHA-mediated growth cone collapse Reactome 2 / 20 80.1× 2.73e-4 4.98e-3 ✓ sig.
Regulation of signaling by CBL Reactome 2 / 21 76.3× 3.02e-4 5.39e-3 ✓ sig.
Oxidative Stress Induced Senescence Reactome 3 / 125 19.2× 4.57e-4 7.43e-3 ✓ sig.
MicroRNAs in cancer KEGG 4 / 311 10.3× 4.80e-4 7.72e-3 ✓ sig.
HCMV Early Events Reactome 3 / 135 17.8× 5.72e-4 8.86e-3 ✓ sig.
Yersinia infection KEGG 3 / 138 17.4× 6.10e-4 9.32e-3 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
facultative heterochromatin formation GO:0140718 3 / 7 534× 1.46e-8 2.38e-6 ✓ sig.
liver development GO:0001889 3 / 87 43.0× 4.26e-5 1.60e-3 ✓ sig.
positive regulation of protein serine/threonine kinase activity GO:0071902 2 / 15 166× 6.28e-5 2.13e-3 ✓ sig.
cardiac muscle tissue development GO:0048738 2 / 24 104× 1.64e-4 4.39e-3 ✓ sig.
chromatin organization GO:0006325 4 / 449 11.1× 3.64e-4 7.65e-3 ✓ sig.
oligodendrocyte differentiation GO:0048709 2 / 45 55.4× 5.84e-4 1.06e-2 ✓ sig.
endothelial cell migration GO:0043542 2 / 48 51.9× 6.64e-4 1.15e-2 ✓ sig.
determination of bilateral symmetry GO:0009855 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure GO:0001998 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
alpha-beta T cell lineage commitment GO:0002363 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
mitotic cleavage furrow formation GO:1903673 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
regulation of peptidyl-serine phosphorylation GO:0033135 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
regulation of RNA polymerase II regulatory region sequence-specific DNA binding GO:1903025 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
response to butyrate GO:1903544 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.
hepatocyte homeostasis GO:0036333 1 / 1 1,246× 8.03e-4 1.30e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Clapo syndrome Congenital malformation syndromes involving early overgrowth 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital intestinal duplication Congenital macrodactylia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital intestinal duplication Congenital malformation syndromes involving early overgrowth 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital intestinal duplication Hemifacial myohyperplasia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital macrodactylia Congenital malformation syndromes involving early overgrowth 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital macrodactylia Hemifacial myohyperplasia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Cloves syndrome Hemifacial myohyperplasia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Cloves syndrome Congenital malformation syndromes involving early overgrowth 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Cloves syndrome Congenital macrodactylia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Cloves syndrome Congenital intestinal duplication 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Clapo syndrome Hemifacial myohyperplasia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Clapo syndrome Congenital macrodactylia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Clapo syndrome Congenital intestinal duplication 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Clapo syndrome Cloves syndrome 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital malformation syndromes involving early overgrowth Hemifacial myohyperplasia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Clapo syndrome Hemihyperplasia multiple lipomatosis syndrome 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Cloves syndrome Hemihyperplasia multiple lipomatosis syndrome 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital intestinal duplication Hemihyperplasia multiple lipomatosis syndrome 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital macrodactylia Hemihyperplasia multiple lipomatosis syndrome 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital malformation syndromes involving early overgrowth Hemihyperplasia multiple lipomatosis syndrome 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Capillary-lymphatic-venous malformation Cloves syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Capillary-lymphatic-venous malformation Clapo syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Capillary-lymphatic-venous malformation Congenital intestinal duplication 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Capillary-lymphatic-venous malformation Congenital macrodactylia 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Capillary-lymphatic-venous malformation Congenital malformation syndromes involving early overgrowth 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Congenital malformation syndromes involving early overgrowth Vascular malformation 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Congenital macrodactylia Vascular malformation 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Congenital intestinal duplication Vascular malformation 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Cloves syndrome Vascular malformation 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Clapo syndrome Vascular malformation 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Cloves syndrome Congenital hemihypertrophy 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Charcot-Marie-Tooth disease type 2A1 Congenital hemihypertrophy 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Charcot-Marie-Tooth disease type 4C Congenital hemihypertrophy 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Clapo syndrome Congenital hemihypertrophy 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Congenital hemihypertrophy Congenital intestinal duplication 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Congenital malformation syndromes involving early overgrowth Diaphragmatic malformations 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Congenital macrodactylia Diaphragmatic malformations 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Congenital intestinal duplication Diaphragmatic malformations 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Cloves syndrome Diaphragmatic malformations 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Upper extremity deformity, congenital Weaver syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Clapo syndrome Diaphragmatic malformations 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Cohen-gibson syndrome Weaver syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Clapo syndrome Weaver syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Cloves syndrome Weaver syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Congenital intestinal duplication Weaver syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.